Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Mundle, SD"'
Autor:
Mundle Sd
Publikováno v:
Leukemia. 16:960-961
Comment on ‘Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes’ by S Tauro et al
Autor:
Mundle, SD, Venugopal, P, Cartlidge, JD, Pandav, DV, Broady-Robinson, L, Gezer, S, Robin, EL, Rifkin, SR, Klein, M, Alston, DE, Hernandez, BM, Rosi, D, Alvi, S, Shetty, VT, Gregory, SA, Raza, A
Publikováno v:
Blood; October 1996, Vol. 88 Issue: 7 p2640-2647, 8p
Autor:
Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Agarwal N; Department of Genitourinary Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Bjartell A; Department of Urological Cancer, Skåne University Hospital, Lund University, Malmö, Sweden., Uemura H; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan., Soto AJ; Department of Urology, Hospital Universitario de Jerez de la Frontera, Cadiz, Spain., Bhaumik A; Janssen Research and Development, Titusville, NJ, USA., Böhm J; Janssen-Cilag GmbH, Neuss, Germany., Tran N; Janssen-Cilag GmbH, Neuss, Germany., Krochmann N; Janssen-Cilag GmbH, Neuss, Germany., Nematian-Samani M; Janssen-Cilag GmbH, Neuss, Germany., Mundle SD; Janssen Research and Development, Raritan, NJ, USA., Brookman-May SD; Ludwig-Maximilians-University, Munich, Germany.; Janssen Research and Development, Spring House, PA, USA., Lopez-Gitlitz A; Janssen Research & Development, Los Angeles, CA, USA., McCarthy SA; Janssen Research and Development, Raritan, NJ, USA., Chi K; Department of Medicine, BC Cancer and Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Chowdhury S; Department of Urological Cancer, Guy's, King's, and St. Thomas' Hospitals and Sarah Cannon Research Institute, London, UK.
Publikováno v:
BJU international [BJU Int] 2024 Dec; Vol. 134 (6), pp. 982-991. Date of Electronic Publication: 2024 Jun 28.
Autor:
Gartrell BA; Departments of Oncology and Urology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA. Electronic address: bgartrel@montefiore.org., Phalguni A; Evidence Synthesis, Genesis Research Group, Newcastle upon Tyne, UK., Bajko P; Evidence Synthesis, Genesis Research Group, Newcastle upon Tyne, UK., Mundle SD; Global Medical Affairs, Janssen Research & Development, Raritan, NJ, USA., McCarthy SA; Clinical Research Oncology, Janssen Research & Development, Raritan, NJ, USA., Brookman-May SD; Clinical Research Oncology, Janssen Research & Development, Spring House, PA, USA; Ludwig-Maximilians-University, München, Germany., De Solda F; Global Commercial Strategy Organization, Janssen Global Services, Raritan, NJ, USA., Jain R; Global Commercial Strategy Organization, Janssen Global Services, Raritan, NJ, USA., Yu Ko W; University of British Columbia Men's Health Research Program, Vancouver, BC, Canada., Ploussard G; Department of Urology, La Croix du Sud Hospital, Quint-Fonsegrives, France., Hadaschik B; Department of Urology, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Dec; Vol. 7 (6), pp. 1216-1227. Date of Electronic Publication: 2024 May 13.
Autor:
Freedland SJ; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA. Stephen.Freedland@cshs.org.; Durham VA Medical Center, Durham, NC, USA. Stephen.Freedland@cshs.org., Fernandes L; Global Commercial Strategy Organization, Janssen Pharmaceutica N.V., Beerse, Belgium., De Solda F; Global Commercial Strategy Organization, Janssen Global Services LLC, Raritan, NJ, USA., Buyukkaramikli N; Global Commercial Strategy Organization, Janssen Pharmaceutica N.V., Beerse, Belgium., Mundle SD; Global Medical Affairs, Janssen Research and Development, Raritan, NJ, USA., McCarthy SA; Clinical Research Oncology, Janssen Research and Development, Raritan, NJ, USA., Labson D; Global Commercial Strategy Organization, Janssen Global Services LLC, Raritan, NJ, USA., Yang L; Global Commercial Strategy Organization, Janssen Global Services LLC, Raritan, NJ, USA., Pan F; Global Commercial Strategy Organization, Janssen Global Services LLC, Raritan, NJ, USA., Mir C; Servicio de Urología, Hospital Universitario La Ribera, Valencia, Spain.
Publikováno v:
Targeted oncology [Target Oncol] 2024 Nov 10. Date of Electronic Publication: 2024 Nov 10.
Autor:
Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: eric.small@ucsf.edu., Chi KN; BC Cancer and Vancouver Prostate Centre, Vancouver, BC, Canada., Chowdhury S; Guy's, King's, and St. Thomas' Hospitals and Sarah Cannon Research Institute, London, UK., Bevans KB; Janssen Global Commercial Strategy Organization, Horsham, PA, USA., Bhaumik A; Janssen Research & Development, Titusville, NJ, USA., Saad F; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Chung BH; Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Karsh LI; The Urology Center of Colorado, Denver, CO, USA., Oudard S; Georges Pompidou Hospital, Université Paris Descartes, Paris, France., De Porre P; Janssen Research & Development, Beerse, Belgium., Brookman-May SD; Ludwig-Maximilians-University, Munich, Germany; Janssen Research & Development, Spring House, PA, USA., McCarthy SA; Janssen Research & Development, Raritan, NJ, USA., Mundle SD; Janssen Research & Development, Raritan, NJ, USA., Uemura H; Kindai University Faculty of Medicine, Osaka, Japan., Smith MR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 844-852. Date of Electronic Publication: 2023 Dec 09.
Autor:
Stattin P; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Fleming S; Janssen Global Services, Titusville, NJ, USA., Lin X; Janssen Global Services, Horsham, PA, USA., Lefresne F; Janssen Research & Development, Los Angeles, CA, USA., Brookman-May SD; Janssen Research & Development, Spring House, PA, USA.; Department of Urology, Ludwig-Maximilians-University, Munich, Germany., Mundle SD; Janssen Research & Development, Spring House, PA, USA., Pai H; Janssen Research & Development, Raritan, NJ, USA., Gifkins D; Janssen Research & Development, Raritan, NJ, USA., Robinson D; Department of Urology, Ryhov County Hospital, Jönköping, Sweden., Styrke J; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Garmo H; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Publikováno v:
BJU international [BJU Int] 2024 Jul; Vol. 134 (1), pp. 96-102. Date of Electronic Publication: 2024 Apr 15.
Autor:
Weber M; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany. Electronic address: wolfgang.fendler@uk-essen.de., Ravi Kumar AS; Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Calais J; University of California Los Angeles, Los Angeles, CA, USA., Czernin J; University of California Los Angeles, Los Angeles, CA, USA., Ilhan H; Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany., Saad F; Department of Surgery, Université de Montréal, Montréal, QC, Canada., Kretschmer A; Department of Urology, Ludwig-Maximilians-University, Munich, Germany; Janssen Research & Development, Spring House, PA, USA., Hekimsoy T; Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Brookman-May SD; Department of Urology, Ludwig-Maximilians-University, Munich, Germany; Janssen Research & Development, Spring House, PA, USA., Mundle SD; Janssen Research & Development, Raritan, NJ, USA., Small EJ; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Smith MR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Perez PM; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Hofman MS; Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Eiber M; Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Hadaschik BA; Department of Urology, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Publikováno v:
European urology [Eur Urol] 2024 Jun; Vol. 85 (6), pp. 511-516. Date of Electronic Publication: 2024 Mar 15.
Autor:
Efstathiou E; Houston Methodist, Houston, Texas, USA. Electronic address: eefstathiou@houstonmethodist.org., Merseburger A; University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Liew A; Oxford PharmaGenesis Group Pty Ltd, Melbourne, Australia., Kurtyka K; Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA., Panda O; Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA., Dalechek D; Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA., Heerdegen ACS; Janssen Global Commercial Strategy Organization, Raritan, New Jersey, USA., Jain R; Janssen Global Commercial Strategy Organization, Raritan, New Jersey, USA., De Solda F; Janssen Global Commercial Strategy Organization, Raritan, New Jersey, USA., McCarthy SA; Janssen Research & Development, Raritan, New Jersey, USA., Brookman-May SD; Janssen Research & Development, Spring House, Pennsylvania, USA; Ludwig-Maximilians-University, Munich, Germany., Mundle SD; Janssen Research & Development, Raritan, New Jersey, USA., Yu Ko W; University of British Columbia Men's Health Research Program, Vancouver, British Columbia, Canada., Krabbe LM; Vivantes Hospital Network for Health, Berlin, Germany.
Publikováno v:
ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 103007. Date of Electronic Publication: 2024 May 14.
Autor:
Chowdhury S; Department of Urological Cancer, Guy's, King's & St Thomas' Hospitals, London, UK.; Sarah Cannon Research Institute, London, UK., Bjartell A; Department of Urology, Skåne University Hospital, Lund University, Malmö, Sweden., Agarwal N; Department of Genitourinary Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Chung BH; Department of Urology, Yonsei University College of Medicine & Gangnam Severance Hospital, Seoul, South Korea., Given RW; Department of Urology, Urology of Virginia, Eastern Virginia Medical School, Norfolk, VA, USA., Pereira de Santana Gomes AJ; Department of Clinical Oncology, Liga Norte Riograndense Contra O Cancer, Natal, Brazil., Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Özgüroğlu M; Department of Oncology, Cerrahpaşa School of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Soto ÁJ; Department of Urology, Hospital Universitario de Jerez de la Frontera, Cadiz, Spain., Uemura H; Department of Medicine, Kindai University Faculty of Medicine, Osaka, Japan., Ye DW; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China., Brookman-May SD; Janssen Research & Development, Spring House, PA, USA.; Ludwig-Maximilians-University (LMU), Munich, Germany., Londhe A; Janssen Research & Development, Titusville, NJ, USA., Bhaumik A; Janssen Research & Development, Titusville, NJ, USA., Mundle SD; Janssen Research & Development, Raritan, NJ, USA., Larsen JS; Janssen Research & Development, Los Angeles, CA, USA., McCarthy SA; Janssen Research & Development, Raritan, NJ, USA., Chi KN; Department of Medicine, BC Cancer & Vancouver Prostate Centre, Vancouver, BC, Canada.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Mar; Vol. 20 (10), pp. 563-578. Date of Electronic Publication: 2023 Dec 21.